- Ginkgolide C
-
- $50.00
-
2026-07-27
- CAS:15291-76-6
- Purity: 99.98%
- Supply Ability: 10g
- Ginkgolide C
-
-
2024-04-12
- CAS:15291-76-6
- Min. Order: 1kg
- Purity: 98%
- Supply Ability: 2000ton
- Ginkgolide C
-
-
2023-02-24
- CAS:15291-76-6
- Min. Order: 5mg
- Purity: ≥98%(HPLC)
- Supply Ability: 10 g
|
| | Ginkgolide C Basic information |
| Product Name: | Ginkgolide C | | Synonyms: | GINKGOLIDE C;1,7-DIHYDROXY-GINKGOLIDE A;(1S,2R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11R,11aR)-3-(1,1-Dimethylethyl)hexahydro-2,4,7b,11-tetrahydroxy-8-methyl-9H-1,7a-(epoxymethano)-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione;Gingkolide C;bn52022;GinkgolideA,1,7-dihydroxy-, (1α,7β)-;CGinkgolid;Ginkgolide C,1,7-Dihydroxy-ginkgolide A | | CAS: | 15291-76-6 | | MF: | C20H24O11 | | MW: | 440.4 | | EINECS: | | | Product Categories: | Pharmaceuticals;Inhibitors;chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;Saponins;Intermediates & Fine Chemicals;standardized herbal extract | | Mol File: | 15291-76-6.mol |  |
| | Ginkgolide C Chemical Properties |
| Melting point | >3000 (dec) | | alpha | D24 -14.7° (c = 1 in ethanol) | | Boiling point | 813.8±65.0 °C(Predicted) | | density | 1.72±0.1 g/cm3(Predicted) | | storage temp. | Sealed in dry,Store in freezer, under -20°C | | solubility | DMSO (Slightly), Ethanol (Slightly, Sonicated), Methanol (Slightly, Heated) | | pka | 10.88±0.70(Predicted) | | form | Solid | | color | White to Off-White | | InChIKey | AMOGMTLMADGEOQ-WCHJOOGENA-N | | LogP | 1.719 (est) |
| | Ginkgolide C Usage And Synthesis |
| Description | Ginkgolide C is a flavone first extracted from G. biloba leaves with multiple reported biological functions. It has been identified as a selective platelet activating factor receptor antagonist (IC50 = 37.6 μM). Ginkgolide C has also been shown to increase lipolysis and to inhibit adipogenesis in adipocytes via the activated AMPK pathway. | | Chemical Properties | Crystalline Solid | | Uses | Family of bioactive terpenes treating cardiovascular and cerebrovascular diseases. Specific platelet activating factor (PAF) antagonists. | | Uses | Reference compound for PAF receptors in biological systems. | | IC 50 | AMPK; MMP-9; Sirtuin | | References | [1] PIERRE BRAQUET. Recent progress in ginkgolide research[J]. Medicinal Research Reviews, 1991, 11 3: 295-355. DOI: 10.1002/med.2610110303
[2] CHIAN-JIUN LIOU. Ginkgolide C Suppresses Adipogenesis in 3T3-L1 Adipocytes via the AMPK Signaling Pathway.[J]. Evidence-based Complementary and Alternative Medicine, 2015: 298635. DOI: 10.1155/2015/298635 |
| | Ginkgolide C Preparation Products And Raw materials |
| Raw materials | 9H-1,7a-(Epoxymethano)-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione, 3-(1,1-dimethylethyl)hexahydro-2,7b,11-trihydroxy-8-methyl-4-(phenylmethoxy)-, (1S,2R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11R,11aR)- | | Preparation Products | Ginkgolide B |
|